Please Wait a Moment
X

Articles

19Jul

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- 1st Update

19 Jul, 2018 | Return|

This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.

Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications

Related

Phoenix Laboratory Transition to the VISION Analyzer

On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...

Read More >

Reminder- CTS Form Revisions Implement on September 2, 2019

Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...

Read More >

FDA announces withdrawal of Guidance for ZIKV Testing

We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...

Read More >

Spotlight on CTS AABB Annual Meeting Abstract Posters

CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...

Read More >

Reminder- Check flights and cargo hours for the Labor Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >

Shipping conditions for Monolisa anti-HBs EIA

After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...

Read More >